The AI health tracker getting women heard by their doctors

This article is a part of Startup Spotlight, a series that features young, up-and-coming startups.

Image credit: Timmy Loen

During her third year of medical school, Dr. Ariella Heffernan-Marks battled chronic migraines. Doctors dismissed her pain as anxiety. This experience highlighted the fragmented nature of women’s healthcare and inspired her to launch Ovum AI.

😟 Problem

The global gender health gap costs the economy US$1 trillion annually. Women leaving work for health reasons cause US$150 billion in lost productivity.

Medical research often ignores female cyclical physiology. This leads to dismissed symptoms and fragmented patient care.

💡 Solution

Ovum AI offers an AI infrastructure that acts as a longitudinal memory system for women’s health. The startup offers an app that:

• Consolidates medical reports, wearable data, logged symptoms, and lifestyle information.
• Generates health summaries and appointment-ready questions for clinical visits.
• Captures reproductive health stages and biometrics with strict anonymous consent protocols.

Image credit: Ovum AI

📊 Market size

The global gender health gap currently drains US$1 trillion from the economy. Regional conversations are increasingly recognizing the severe impact of this inequity on workforce participation and overall GDP.

🤝 Team

• Dr. Ariella Heffernan-Marks. Founder. She is also a PhD candidate at the George Institute focusing on AI and women’s health.

🚀 Traction

• Surpassed 20,000 downloads and logged 113,000 AI health conversations since its August launch.
• Achieved 30% month-on-month growth while collecting over 60,000 women’s health data points.
• Secured an enterprise partnership with Medibank prior to launching the core product.
• Landed partnerships with Fernwood Fitness, Sweat, and a pilot with Australian Red Cross Lifeblood.

🏆 Competition

The consumer wellness app market is highly saturated with basic symptom trackers. Ovum AI differentiates itself by providing clinically validated AI infrastructure.

The platform prioritizes strict privacy standards. It is also backed by active clinical trials at major public hospitals.

💰 Financials

🚩 Risks